Short‐ and long‐term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle‐low rectal cancer: Results of a multicentre lateral node study in China

Lateral pelvic lymph node dissection (LPND) is a technically challenging procedure, and the safety and feasibility of laparoscopic LPND remains undetermined. Here, we compared the short‐ and long‐term survival outcomes of laparoscopic LPND with those of open LPND.

[1]  Zhixiang Zhou,et al.  Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications , 2021, Journal of surgical oncology.

[2]  Yoshiyuki Suzuki,et al.  Prognostic impact of the number of lateral pelvic lymph node metastases on rectal cancer. , 2020, Japanese journal of clinical oncology.

[3]  F. Han,et al.  Laparoscopic versus open selective lateral pelvic lymph node dissection following total mesorectal excision for locally advanced low rectal cancer , 2020, International Journal of Colorectal Disease.

[4]  K. Y. Wong,et al.  Short term outcomes of minimally invasive selective lateral pelvic lymph node dissection for low rectal cancer. , 2020, World journal of gastrointestinal surgery.

[5]  Y. Kakeji,et al.  Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy , 2019, Surgical Endoscopy.

[6]  P. Wang,et al.  Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy , 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[7]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.

[8]  Hein Putter,et al.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Masaaki Ito,et al.  Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan , 2017, Diseases of the colon and rectum.

[10]  Y. Kanemitsu,et al.  Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high‐volume centers in Japan that employ different policies concerning LLND , 2017, Surgery.

[11]  K. Sugihara,et al.  Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer , 2016, World Journal of Surgery.

[12]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .

[13]  Y. Oda,et al.  Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach , 2016, Surgical Endoscopy.

[14]  F. Frizelle,et al.  Long-Term Outcomes of the Australasian Randomized Clinical Trial Comparing Laparoscopic and Conventional Open Surgical Treatments for Colon Cancer: The Australasian Laparoscopic Colon Cancer Study Trial , 2012, Annals of surgery.

[15]  T. Muto,et al.  Results of a Japanese Nationwide Multi-Institutional Study on Lateral Pelvic Lymph Node Metastasis in Low Rectal Cancer: Is It Regional or Distant Disease? , 2012, Annals of surgery.

[16]  M. Ohue,et al.  Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. , 2012, The Lancet. Oncology.

[17]  G. Choi,et al.  Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer: initial clinical experience , 2011, Surgical Endoscopy.

[18]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .

[19]  H. Yano,et al.  The incidence of lateral pelvic side‐wall nodal involvement in low rectal cancer may be similar in Japan and the West , 2007, The British journal of surgery.

[20]  J. Fleshman,et al.  Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial , 2008, JAMA.

[21]  K. Shirouzu,et al.  Indication and Benefit of Pelvic Sidewall Dissection for Rectal Cancer , 2006, Diseases of the colon and rectum.

[22]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[23]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.